Trial to test Lymphoseek in patients with colorectal cancer

02/4/2013 | AuntMinnie.com (free registration)

Navidea Biopharmaceuticals has formed a partnership with Maimonides Medical Center in New York that will focus on an open-label clinical trial involving Lymphoseek, a radiopharmaceutical designed to stage cancers by pinpointing the lymph nodes that drain from a primary tumor. The trial will test the agent in patients with colorectal cancer and is set to start in the first half of the year.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL